RNA-Targeted Small Molecules Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global RNA-targeted small
molecules market is anticipated to grow at a significant CAGR during the
forecast period (2021-2027). The conventional clinical delivery of oligonucleotide-based
therapies comes with certain unaddressed challenges of genetic disorders. This
unmet medical need has created promising opportunities for the global
RNA-targeted small molecules market. The ability of small molecules to target
the more complex RNA structures is primarily anticipated to drive market
growth. As of 2020, out of the 55 US FDA-approved drugs, more than 65% of them
were small molecule therapeutics; the majority of which were conventionally
developed to target proteins.
Although just 2% of the human
genome is allegedly responsible for coding proteins. This is why, therapies are
now focused on evaluating previously untapped targets, such as non-coding DNA
and RNA. For instance, in January 2022, HotSpot Therapeutics and Caris Life
Sciences had collaborated to advance precision medicine approaches for
HotSpot's emerging product portfolio. The partnership will focus initially on
two therapeutic programs, the first of which is HotSpot's novel allosteric
inhibitor of the E3 ubiquitin ligase CBL-B, an important target in cancer
immunotherapy, spanning from pre-First in Human (FIH) trials through potential
Companion Diagnostics (CDx) and launch.
To Request a Sample of our Report on RNA-Targeted Small
Molecules Market: https://www.omrglobal.com/request-sample/rna-targeted-small-molecules-market
The global RNA-targeted small molecules market is
anticipated to grow at a significant CAGR during the forecast period
(2021-2027). The conventional clinical delivery of oligonucleotide-based
therapies comes with certain unaddressed challenges of genetic disorders. This unmet
medical need has created promising opportunities for the global RNA-targeted
small molecules market. The ability of small molecules to target the more
complex RNA structures is primarily anticipated to drive market growth. As of
2020, out of the 55 US FDA-approved drugs, more than 65% of them were small
molecule therapeutics; the majority of which were conventionally developed to
target proteins.
Although just 2% of the human genome is allegedly
responsible for coding proteins. This is why, therapies are now focused on
evaluating previously untapped targets, such as non-coding DNA and RNA. For
instance, in January 2022, HotSpot Therapeutics and Caris Life Sciences had
collaborated to advance precision medicine approaches for HotSpot's emerging
product portfolio. The partnership will focus initially on two therapeutic
programs, the first of which is HotSpot's novel allosteric inhibitor of the E3
ubiquitin ligase CBL-B, an important target in cancer immunotherapy, spanning
from pre-First in Human (FIH) trials through potential Companion Diagnostics
(CDx) and launch.
(Get 15% Discount on Buying this Report)
A
full Report of RNA-Targeted Small Molecules Market is Available @ https://www.omrglobal.com/industry-reports/rna-targeted-small-molecules-market
Global RNA Targeted Small Molecules Market Report by Segment
By Product Type
·
mRNA Translation Regulation
·
RNA Splicing Modification
·
Direct RNA Targeting
·
Indirect RNA Targeting-Epitranscriptomics
By Application
·
Drug Discovery
·
Disease Identification
·
Oncology Research
By End-User
·
Hospitals
·
Research Laboratories
·
Contract Research Organizations
·
Pharmaceutical and Biotechnology Companies
Global RNA Targeted Small Molecules Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment